The Australian and New Zealand Hip Fracture Registry based at NeuRA, released its 2017 report highlighting hip fracture as the most serious and costly fall-related injury suffered by older Australians. In 2016, there were approximately 22,000 hip fractures in Australia with an estimated combined direct and indirect cost of $908 million.
Commenting on the seriousness of these statistics, Prof Jaqueline Close, Geriatrician and Co-Chair of the Australian and New Zealand Hip Fracture Registry said “the number is set to rise to more than 30,000 by 2022, with a projected cost of $1.126 billion”.
“Most importantly, the human cost from this injury is high: 5% will die in hospital; over 10% will be newly discharged to an aged care facility; more than 50% will still experience a mobility-related disability 12 months after injury; and up to 25% will have died in the year after discharge from hospital.” The report highlighted the performance against national clinical care standards which have the potential to alter the outcome for some of the frailest members of our society.
Commenting on the findings, Prof Ian Harris, orthopaedic surgeon and Co-Chair of the Australian and New Zealand Hip Fracture Registry said, “This report continues to show variation in the way we deliver care to people with a hip fracture. Some of this variation between hospitals can markedly change the experience for the older person including how we manage their pain, timing of the surgery and the opportunity to start walking again after surgery”.
Further commenting, Prof Close said, “there remain huge opportunities to further improve care including the prevention of future falls and fractures. Strong evidence exists to support treatment of osteoporosis in this population yet there remains a care gap between what we are and should be doing.”
This care gap leaves hip fracture survivors with an increased risk of subsequent falls and fractures that are associated with loss of independence or ultimately increased risk of death.
More than 80,000 people are living with Parkinson’s disease in Australia, and of these, approximately two thirds will fall each year. Ensuing injuries, hospitalisations, fear of falling and caregiver burden are devastating, widespread and costly. As the prevalence of Parkinson’s disease will double between 2010 and 2040, the associated human and economic burden will also grow. Innovative therapies to improve […]